Marrone Bio Innovations I...

NASDAQ: MBII · Real-Time Price · USD
0.80
-0.20 (-20.00%)
At close: Apr 24, 2025, 3:47 PM

Marrone Bio Innovations Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
9.36M 19.62M 15.04M 17.46M 18.92M
Short-Term Investments
n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a
Other Long-Term Assets
2.3M 2.31M 2.44M 2.45M 2.47M
Receivables
12.11M 13.21M 12.99M 14.5M 13.53M
Inventory
10.12M 8.63M 8.52M 6.48M 6.41M
Other Current Assets
1.37M 1.21M 861K 1.59M 1.35M
Total Current Assets
32.96M 42.68M 37.42M 40.04M 40.22M
Property-Plant & Equipment
15.79M 16.31M 15.92M 16.17M 16.24M
Goodwill & Intangibles
25.17M 25.75M 26.37M 26.95M 27.54M
Total Long-Term Assets
43.25M 44.38M 44.72M 45.58M 46.24M
Total Assets
76.21M 87.06M 82.14M 85.62M 86.47M
Account Payables
3.36M 2.69M 3.02M 1.76M 2.19M
Deferred Revenue
285K 360K 346K 388K 439K
Short-Term Debt
25.71M 27.29M 11.64M 13.4M 13.25M
Other Current Liabilities
12.35M 14.85M 12.38M 10.94M 10.15M
Total Current Liabilities
41.71M 45.19M 27.39M 26.49M 26.03M
Long-Term Debt
9.74M 10.2M 20.91M 21.28M 21.6M
Other Long-Term Liabilities
807K 848K 1.97M 1.84M 1.95M
Total Long-Term Liabilities
11.63M 12.21M 24.12M 24.45M 25.08M
Total Liabilities
53.34M 57.4M 51.51M 50.94M 51.11M
Total Debt
35.46M 37.49M 32.55M 34.68M 34.85M
Common Stock
1K 1K 1K 1K 1K
Retained Earnings
-364.97M -357.37M -352.06M -347.11M -344.08M
Comprehensive Income
n/a n/a n/a n/a n/a
Shareholders Equity
22.87M 29.65M 30.63M 34.68M 35.35M
Total Investments
n/a n/a n/a n/a n/a